SCHEMBL3626425

SCHEMBL3626425

Cc1ccc(Nc2cccc3c2CCN([C]2CC2)C3)cc1-c1nc2ccccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDLR P01130 1/20 0.42
HDAC11 Q96DB2 4/20 0.42
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDR P35968 4/20 0.40
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
CASP1 P29466 1/20 0.38
BRCA1 P38398 1/20 0.38
CASP7 P55210 1/20 0.38
HBB P68871 1/20 0.38
HDAC6 Q9UBN7 2/20 0.36
FASN P49327 1/20 0.36
BACE1 P56817 2/20 0.36
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3626429 0.86 LDLR (0.45) LDLRHDAC11HPGDSMN1; SMN2NPC1
SCHEMBL1923364 0.85 LDLR (0.44) LDLRHDAC11HPGDSMN1; SMN2NPC1
SCHEMBL304418 0.83 LDLR (0.41) LDLRHDAC11HPGDSMN1; SMN2NPC1
SCHEMBL2031910 0.82 LDLR (0.42) LDLRHDAC11HPGDSMN1; SMN2NPC1
SCHEMBL303820 0.81 LDLR (0.43) LDLRHDAC11HPGDSMN1; SMN2NPC1
SCHEMBL304307 0.80 LDLR (0.46) LDLRHDAC11SMN1; SMN2KDRTP53
SCHEMBL3658672 0.77 MAPT (0.36) TP53MAPTLMNAGAA
SCHEMBL303622 0.75 PTGDR2 (0.41) LDLRHPGDSMN1; SMN2ALDH1A1HTT
SCHEMBL27935545 0.75 LDLR (0.36) LDLRHDAC11HPGDALDH1A1NPSR1
SCHEMBL302156 0.75 LDLR (0.41) LDLRHPGDSMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010027746-A2 HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2010-03-11 WO claimed